Ironwood Pharmaceuticals

We are spotlighting new patient demographic analyses at #ACG2024. Click here to learn more about our oral presentation and posters, which include two Presidential Poster recipients: https://ow.ly/98U550TUihf #GI #digestivehealth #WorkinginGIHealth

October marks #NationalPharmacistMonth, and we’re spotlighting some of our pharmacists who work to transform the lives of #GI patients. Today, and every day, we appreciate the dedication of all our Ironwoodian pharmacists. #digestivehealth #WorkinginGIHealth

#DYK the signs, symptoms and potential complications of #shortbowelsyndrome (SBS)? Take a look at a few below, and visit our website designed for US health care professionals (#HCPs), for more information: https://ow.ly/929e50TQQ14 #SBS #shortgut

#ACG2024 is almost here! We’ll be presenting a new study on our investigational glucagon-like peptide 2 (GLP-2) agonist in patients with #shortbowelsyndrome with intestinal failure (#SBS-IF), as well as four new studies related to #IBS-C and #CIC. Stay tuned for more! #GI #digestivehealth #WorkinginGIHealth

Join us in welcoming two new Ironwoodians! Andrea Stancati M.D. joins us as Head of R&D based in Basel, and Simon Levett joins us as Head of Quality. Andrea has over 18 years of experience in the #pharmaceutical industry, and has held various leadership roles across therapeutic areas. Outside of work, he is passionate about cooking and enjoys foil-surfing and combat sports. Simon has over 20 years of experience in pharmaceutical and biotech sectors across global markets, and his commitment to quality and #patientsafety drives him to prioritize communication and collaboration. They bring robust experience and expertise and strengthen our commitment to excellence and innovation. Welcome to Ironwood, Andrea and Simon! #WorkinginGIHealth #biotech

#UEGW2024 is here! We’re thrilled to share findings from our investigational glucagon-like peptide 2 agonist in adult patients with short bowel syndrome with intestinal failure. Here’s a sneak peek at our upcoming data! #UEGWeek #IngestTheBest #WorkinginGIHealth

Kudos to the American Society for Gastrointestinal Endoscopy (ASGE) for its recent and successful National Colorectal Cancer (CRC) Screening Summit! This important online event discussed ways to increase the CRC screening rate for underserved patients in the US.   We’re proud to continue our support of ASGE’s effort to improve colon cancer screenings for patients in underserved communities – an initiative that was recently recognized by the White House and The Biden Cancer Moonshot program earlier this year. Learn more about the initiative: https://ow.ly/X59I50RtYkB   #WorkinginGIHealth #ASGE #biotech

#DYK? While estimates vary, as many as 11.5 million adults in the U.S. may have IBS-C. If you’re struggling with #IBS-C symptoms, know that you’re not alone and there are options available to you! Speak to your doctor about IBS-C treatment options today. #GI #digestivehealth

Functional constipation accounts for 10-25% of all visits to #pediatric gastroenterologists. As part of our commitment to advancing care, we partnered with Alimentary Pharmacology and Therapeutics to share articles and videos on the disease’s pathology, testing and management. Learn more about functional constipation in AP&T: https://ow.ly/AcrE50TvPcc #WorkinginGIHealth

This year’s #WorldPharmacistsDay theme of Meeting Global Health Needs is an important reminder of the impact our work has on countless lives. Today, and every day, we’re proud of our pharmacists helping to create a brighter future for #GI patients across the globe. #WorkingInGIHealth